Zero fluoroscopy catheter ablation of premature ventricular contractions: a multicenter experience
ConclusionsThe PVC ablation with a “zero” fluoroscopy approach appears to be a safe procedure with no major complications and good rates of success and recurrence in our multicenter experience. (Source: Journal of Interventional Cardiac Electrophysiology)
Source: Journal of Interventional Cardiac Electrophysiology - December 16, 2023 Category: Cardiology Source Type: research

Severe coronary spasm occurring remotely from pulsed field application during right inferior pulmonary vein isolation
(Source: Journal of Interventional Cardiac Electrophysiology)
Source: Journal of Interventional Cardiac Electrophysiology - December 16, 2023 Category: Cardiology Source Type: research

Zero fluoroscopy catheter ablation of premature ventricular contractions: a multicenter experience
ConclusionsThe PVC ablation with a “zero” fluoroscopy approach appears to be a safe procedure with no major complications and good rates of success and recurrence in our multicenter experience. (Source: Journal of Interventional Cardiac Electrophysiology)
Source: Journal of Interventional Cardiac Electrophysiology - December 16, 2023 Category: Cardiology Source Type: research

Severe coronary spasm occurring remotely from pulsed field application during right inferior pulmonary vein isolation
(Source: Journal of Interventional Cardiac Electrophysiology)
Source: Journal of Interventional Cardiac Electrophysiology - December 16, 2023 Category: Cardiology Source Type: research

ICD early after myocardial infarction: it is really necessary to wait 40  days before implantation?
Graphical AbstractESC Guidelines don ’t recommend ICD implantation within 40 days after MI, on the basis of old evidence with several limitations. However, a significant number of patients remain at high risk of arrhythmic death also in the early period after ACS, in these patients early ICD implantation or LifeVest may be use with benefit on survival. (Source: Journal of Interventional Cardiac Electrophysiology)
Source: Journal of Interventional Cardiac Electrophysiology - December 15, 2023 Category: Cardiology Source Type: research

High efficiency single-catheter workflow for radiofrequency atrial fibrillation ablation in the QDOT catheter era
ConclusionA streamlined single-catheter workflow for PVI using QDOT was feasible and safe, resulting in a high rate of first-pass isolation and a low complication rate. The Q-FLOW further improved the efficiency of PVI compared to the standard CMC-FLOW, without difference in the 12-month outcome. (Source: Journal of Interventional Cardiac Electrophysiology)
Source: Journal of Interventional Cardiac Electrophysiology - December 14, 2023 Category: Cardiology Source Type: research

Technological advances in ventricular tachycardia catheter ablation: the relentless quest for novel solutions to old problems
ConclusionThe ideation and development of novel technologies initially intended to treat atrial arrhythmias and successfully implemented in the ventricular milieu is contributing to the progressive improvement in the clinical benefits derived from VT CA, making this procedure key for successful management of increasingly complex patients.Graphical abstract (Source: Journal of Interventional Cardiac Electrophysiology)
Source: Journal of Interventional Cardiac Electrophysiology - December 13, 2023 Category: Cardiology Source Type: research

Does conduction system pacing result in a lower atrial arrhythmia burden compared to right ventricular pacing?
(Source: Journal of Interventional Cardiac Electrophysiology)
Source: Journal of Interventional Cardiac Electrophysiology - December 13, 2023 Category: Cardiology Source Type: research

Technological advances in ventricular tachycardia catheter ablation: the relentless quest for novel solutions to old problems
ConclusionThe ideation and development of novel technologies initially intended to treat atrial arrhythmias and successfully implemented in the ventricular milieu is contributing to the progressive improvement in the clinical benefits derived from VT CA, making this procedure key for successful management of increasingly complex patients.Graphical abstract (Source: Journal of Interventional Cardiac Electrophysiology)
Source: Journal of Interventional Cardiac Electrophysiology - December 13, 2023 Category: Cardiology Source Type: research

Does conduction system pacing result in a lower atrial arrhythmia burden compared to right ventricular pacing?
(Source: Journal of Interventional Cardiac Electrophysiology)
Source: Journal of Interventional Cardiac Electrophysiology - December 13, 2023 Category: Cardiology Source Type: research

Characteristics of two different cryoballoon systems for treatment of paroxysmal atrial fibrillation: study protocol for a multicenter randomized controlled trial (CONTRAST-CRYO Trial)
ConclusionThe CONTRAST-CRYO trial is a prospective, multicenter, randomized study designed to elucidate the difference in the efficacy, safety, and biophysical parameters between POLARx ™ and AFA-Pro in paroxysmal AF patients undergoing PVI. The findings from this trial may provide a valuable indication for selecting the optimal cryoballoon system.Clinical Trial registration:  UMIN000049948 (Source: Journal of Interventional Cardiac Electrophysiology)
Source: Journal of Interventional Cardiac Electrophysiology - December 12, 2023 Category: Cardiology Source Type: research

Cryoballoon ablation of atrial fibrillation in octogenarians: one year outcomes from the cryo global registry
ConclusionsDespite more age-related comorbidities, CBA is a safe and effective treatment for AF in octogenarians, with efficacy and adverse events rates akin to ablations performed in younger patients.Clinical trial registrationhttps://clinicaltrials.gov/ct2/show/NCT02752737Graphical Abstract (Source: Journal of Interventional Cardiac Electrophysiology)
Source: Journal of Interventional Cardiac Electrophysiology - December 12, 2023 Category: Cardiology Source Type: research

Characteristics of two different cryoballoon systems for treatment of paroxysmal atrial fibrillation: study protocol for a multicenter randomized controlled trial (CONTRAST-CRYO Trial)
ConclusionThe CONTRAST-CRYO trial is a prospective, multicenter, randomized study designed to elucidate the difference in the efficacy, safety, and biophysical parameters between POLARx ™ and AFA-Pro in paroxysmal AF patients undergoing PVI. The findings from this trial may provide a valuable indication for selecting the optimal cryoballoon system.Clinical Trial registration:  UMIN000049948 (Source: Journal of Interventional Cardiac Electrophysiology)
Source: Journal of Interventional Cardiac Electrophysiology - December 12, 2023 Category: Cardiology Source Type: research